We present a case of chemosis (conjunctival edema) as an early manifestation of severe systemic lupus erythematosus affecting multiple organs, including the central nervous system and the kidneys.
Ward MM, Studenski S.The time course of acute psychiatric episodes in systemic lupus erythematosus . J Rheumatol1991; 18: 535-539.
2.
Pego-Reigosa JM, Isenberg DAPsychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease . Rheumatology (Oxford ) 2008; 47: 1498-1502.
3.
Nguyen QD, Foster CSSystemic lupus erythematosus and the eye. Int Ophthalmol Clin1998; 38: 33-60.
4.
Jankauskiene A., Buteikiene I.Severe chemosis in a patient with nephrotic syndrome. Eur J Pediatr2009; 168: 507-508.
5.
Frith P., Burge SM, Millard PR, Wojnarowska F.External ocular findings in lupus erythematosus: a clinical and immunopathological study. Br J Ophthalmol1990; 74: 163-167.
6.
Heiligenhaus A., Dutt JE, Foster CSHistology and immunopathology of systemic lupus erythematosus affecting the conjunctiva. Eye ( London, England) 1996; 10: 425-432.
7.
Smith CA, Pinals RSPeriorbital edema in systemic lupus erythematosus. Archives Int Med1982; 142: 1711-1712.
8.
Shu U., Takeuchi F., Tanimoto K., Moroi Y., Uchida K., Ito K.Transient myopia with severe chemosis associated with exacerbation of disease activity in systemic lupus erythematosus. J Rheumatol1992; 19: 297-301.
9.
Norden D., Weinberg J., Schumacher HR, Keenan G., Freundlich B.Bilateral periorbital edema in systemic lupus erythematosus. J Rheumatol1993; 20: 2158-2160.
Gomez-Puerta JA, Levy S., Khamashta MA, Hughes GRPeriorbital oedema in systemic lupus erythematosus . Lupus2003 ; 12: 866-869.
12.
Kwok AK, Wong SM, Lam SW, Lam DSRecurrent cerebral lupus heralded by an unusual combination of ocular manifestations . Eye (London, England ) 2001; 15: 559-561.
13.
Lee JY, Huerta PT, Zhang J., et al. Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat Med2009 ; 15: 91-96.
14.
Kowal C., Degiorgio LA, Lee JY, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci USA2006; 103: 19854-19859.
15.
Widner B., Sepp NE, Kowald E., et al. Enhanced tryptophan degradation in systemic lupus erythematosus . Immunobiology2000; 201: 621-630.
16.
Vogelgesang SA, Heyes MP, West SG, et al. Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations . J Rheumatol1996; 23: 850-855.
17.
Barile-Fabris L., Ariza-Andraca R., Olguin-Ortega L., et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis2005; 64: 620-625.
18.
Levy Y., Sherer A., Ahmed A., et al. A study of 20 SLE patients with intravenous immunoglobulin-clinical and serologic response. Lupus1999; 8: 705-712.
19.
Valesini G. , Priori R., Francia A., et al. Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate. Springer Semin Immunopathol1994; 16: 313-321.
